Murine ACE2 does not efficiently bind the SARS-CoV-2 spike (S) protein, hindering viral entry into murine cells; consequently, human ACE2 transgenic and knock-in mice have been developed to study in vivo the infection and pathogenesis of SARS-CoV-2[16–19]. The gene discussed is ACE2; the disease is infection.